Molecular biology of colorectal cancer in clinical practice
- 1 July 2015
- journal article
- Published by Pleiades Publishing Ltd in Molecular Biology
- Vol. 49 (4) , 471-479
Abstract
The review summarizes current data on the molecular genetic mechanisms underlying the pathogenesis of colorectal cancer (CRC) and addresses the connections between these mechanisms and biomarkers used for predictive diagnosis, risk stratification, prognosis, and predicting response to chemotherapy and tar-geted therapy. Evidence of microRNA involvement in the regulation of major signaling pathways affected by CRC pathogenesis is discussed, and signaling pathways that can be used as targets in the therapy of colorectal cancer are examined.Keywords
This publication has 51 references indexed in Scilit:
- Biomarkers Predicting Clinical Outcome of Epidermal Growth Factor Receptor–Targeted Therapy in Metastatic Colorectal CancerJNCI: Journal of the National Cancer Institute, 2009
- Genetic prognostic and predictive markers in colorectal cancerNature Reviews Cancer, 2009
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal CancerNew England Journal of Medicine, 2008
- Hypermethylator Phenotype in Sporadic Colon Cancer: Study on a Population-Based Series of 582 CasesCancer Research, 2008
- Genomic and Epigenetic Instability in Colorectal Cancer PathogenesisGastroenterology, 2008
- Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysisGut, 2008
- BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testingJournal of Medical Genetics, 2004
- Development of a Fluorescent Multiplex Assay for Detection of MSI‐High TumorsDisease Markers, 2004
- Histopathological Identification of Colon Cancer with Microsatellite InstabilityThe American Journal of Pathology, 2001
- Genetic Alterations during Colorectal-Tumor DevelopmentNew England Journal of Medicine, 1988